Blue Trust’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$534 Buy
40
+10
+33% +$145 ﹤0.01% 2278
2026
Q2
$446 Sell
30
-1
-3% -$11 ﹤0.01% 2363
2026
Q1
$262 Sell
31
-62
-67% -$678 ﹤0.01% 2395
2025
Q4
$1.05K Buy
93
+62
+200% +$768 ﹤0.01% 2278
2025
Q3
$465 Hold
31
– – ﹤0.01% 2431
2025
Q2
$437 Buy
31
+5
+19% +$89 ﹤0.01% 2330
2025
Q1
$625 Hold
26
– – ﹤0.01% 2335
2024
Q4
$971 Buy
26
+12
+86% +$560 ﹤0.01% 2284
2024
Q3
$486 Hold
14
– – ﹤0.01% 2795
2024
Q2
$766 Hold
14
– – ﹤0.01% 2569
2024
Q1
$766 Buy
14
+3
+27% +$149 ﹤0.01% 1974
2023
Q4
$0 Hold
11
– – ﹤0.01% 2487
2023
Q3
$0 Buy
+11
New +$229 ﹤0.01% 2042
2023
Q2
– Sell
-48
Closed -$1K – 2037
2023
Q1
$1K Buy
+48
New +$764 ﹤0.01% 2109

Other funds holding BHVN

Blue Trust's BHVN Position: Q3 2026 in Review

Blue Trust increased its Biohaven (BHVN) stake by 33% in Q3 2026, buying an estimated $145 and bringing the position to 40 shares worth $534. The position accounts for ﹤0.01% of the portfolio, ranked #2278.

Blue Trust first reported a position in BHVN in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.05K in Q4 2025. 223 funds tracked by Wall St. Rank hold BHVN as of Q3 2026.

  • Blue Trust held 40 shares of Biohaven worth $534 as of Q3 2026.
  • Blue Trust bought 10 Biohaven shares in Q3 2026, an estimated $145.
  • Biohaven made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2278 holding.
  • Blue Trust first reported a position in Biohaven in Q1 2023 and has held it in 14 quarters since.
  • Blue Trust's Biohaven position peaked at $1.05K in Q4 2025.
  • 223 funds tracked by Wall St. Rank held Biohaven as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.